FDA Drug recall D1834-2015
Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp
- FDA Drug
- Class III
- terminated
- Published 2015-10-07
On 2015-10-07 the FDA classified a Class III recall of Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp by Apotex, citing failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D1834-2015 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2015-07-21 |
| Published | 2015-10-07 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Apotex |
| Distribution | US |
Product
Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.
Reason
Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.
Identifiers
| code_info | Lot #: KP2621, Exp 8/2015 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D1834-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.